Skip to main content
Top
Published in: Clinical Rheumatology 1/2019

01-01-2019 | Original Article

Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort

Authors: Xin-yao Wu, Min Yang, Yue-sheng Xie, Wei-guo Xiao, Jin Lin, Bin Zhou, Xin Guan, Cai-nan Luo, Nan Che, Xing-zhen Liu, Chao Wang, Jia-lin Teng, Xiao-bing Cheng, Jun-na Ye, Yu-tong Su, Hui Shi, Yu-feng Yin, Meng-ru Liu, Yue Sun, Qiong-Yi Hu, Zhuo-chao Zhou, Hui-hui Chi, Yi Liu, Xiao Zhang, Jin-wei Chen, Miao-jia Zhang, Dong-bao Zhao, Cheng-de Yang, Li-jun Wu, Hong-lei Liu

Published in: Clinical Rheumatology | Issue 1/2019

Login to get access

Abstract

To estimate the mortality and describe the causes of death in a large multicenter cohort of hospitalized patients with SLE in China. This was a retrospective study of a nationwide SLE cohort (10 centers, 29,510 hospitalized patients) from 2005 to 2014 in China. Standardized mortality ratios (SMRs) were calculated for all death and were stratified by sex and age. Chi-square test was used to determine whether the major causes of death vary in age, sex, duration of SLE, disease activity, or medications. Comparison between dead patients and survival controls was used to identify the risk factors for mortality. Logistic regression analysis was used to evaluate the risk factors for mortality. A total of 360 patients died during the study period, accounting for 1.22%. The overall SMR was 2.13 (95% CI 1.96, 2.30), with a particularly high SMR seen in subgroups characterized by younger age. Infection (65.8%) was the most common cause of death, followed by lupus nephritis (48.6%), hematological abnormality (18.1%), neuropsychiatric lupus/NPSLE (15.8%), and interstitial pneumonia (13.1%). Cardiovascular disease and malignancy contributed little to the causes of death. Infection, in particular severe pulmonary infection, emerged as the foremost risk factor for mortality, followed by lupus encephalopathy. However, lupus nephritis and hematological abnormalities occurred more frequently in survival patients. SLE patients at a younger age of diagnosis have a poorer prognosis. Infection dominated the causes of death in recent China. Ethnicity and medications might account for the differences in causes of death compared with western populations.
Literature
1.
go back to reference Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME (2004) Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmun Rev 3:423–453CrossRefPubMed Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME (2004) Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmun Rev 3:423–453CrossRefPubMed
2.
go back to reference Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GF et al (2012) Treatment for lupus nephritis. The Cochrane database of systematic reviews, p CD002922 Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GF et al (2012) Treatment for lupus nephritis. The Cochrane database of systematic reviews, p CD002922
3.
go back to reference Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'fallon WM, Gabriel SE (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 42:46–50CrossRefPubMed Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'fallon WM, Gabriel SE (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 42:46–50CrossRefPubMed
4.
go back to reference Wang Z, Wang Y, Zhu R, Tian X, Xu D, Wang Q et al (2015) Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine:e794 Wang Z, Wang Y, Zhu R, Tian X, Xu D, Wang Q et al (2015) Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine:e794
5.
go back to reference Alamanos Y, Voulgari PV, Papassava M, Tsamandouraki K, Drosos AA (2003) Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21-year incidence cohort. Rheumatology:1122–1123 Alamanos Y, Voulgari PV, Papassava M, Tsamandouraki K, Drosos AA (2003) Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21-year incidence cohort. Rheumatology:1122–1123
6.
go back to reference Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, Atzeni F, Piccoli A, Todesco S (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119:700–706CrossRefPubMed Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, Atzeni F, Piccoli A, Todesco S (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119:700–706CrossRefPubMed
7.
go back to reference Lerang K, Gilboe IM, Steinar Thelle D, Gran JT (2014) Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study. Lupus:1546–1552 Lerang K, Gilboe IM, Steinar Thelle D, Gran JT (2014) Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study. Lupus:1546–1552
8.
go back to reference Fors Nieves CE, Izmirly PM (2016) Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep:21 Fors Nieves CE, Izmirly PM (2016) Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep:21
9.
go back to reference Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcón G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, el-Gabalawy H, McCarthy T, St. Pierre Y, Clarke A, Ramsey-Goldman R (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54:2550–2557CrossRefPubMed Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcón G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, el-Gabalawy H, McCarthy T, St. Pierre Y, Clarke A, Ramsey-Goldman R (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54:2550–2557CrossRefPubMed
10.
go back to reference Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA (2014) Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res 66:608–616CrossRef Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA (2014) Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res 66:608–616CrossRef
11.
go back to reference Dubois EL, Wierzchowiecki M, Cox MB, Weiner JM (1974) Duration and death in systemic lupus erythematosus. An analysis of 249 cases. Jama:1399–1402 Dubois EL, Wierzchowiecki M, Cox MB, Weiner JM (1974) Duration and death in systemic lupus erythematosus. An analysis of 249 cases. Jama:1399–1402
12.
go back to reference Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL (1981) Systemic lupus erythematosus--survival patterns. Experience with 609 patients. Jama:934–938 Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL (1981) Systemic lupus erythematosus--survival patterns. Experience with 609 patients. Jama:934–938
13.
go back to reference Rees F, Doherty M, Grainge MJ, Lanyon P, Davenport G, Zhang W (2016) Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012. Rheumatology:854–860 Rees F, Doherty M, Grainge MJ, Lanyon P, Davenport G, Zhang W (2016) Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012. Rheumatology:854–860
14.
go back to reference Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221–225CrossRefPubMed Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221–225CrossRefPubMed
15.
go back to reference Reveille JD, Bartolucci A, Alarcon GS (1990) Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum:37–48 Reveille JD, Bartolucci A, Alarcon GS (1990) Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum:37–48
16.
go back to reference Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum 38:1492–1499CrossRefPubMed Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum 38:1492–1499CrossRefPubMed
17.
go back to reference Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine:299–308 Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine:299–308
18.
go back to reference Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA (2002) Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis:409–413 Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA (2002) Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis:409–413
19.
go back to reference Mok CC, Mak A, Chu WP, Toa CH, Wong SN (2005) Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine:218–224 Mok CC, Mak A, Chu WP, Toa CH, Wong SN (2005) Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine:218–224
20.
go back to reference Wu G, Jia X, Gao D, Zhao Z (2014) Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center. Clin Rheumatol 33:947–953CrossRefPubMed Wu G, Jia X, Gao D, Zhao Z (2014) Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center. Clin Rheumatol 33:947–953CrossRefPubMed
21.
go back to reference Feng X, Zou Y, Pan W, Wang X, Wu M, Zhang M et al (2011) Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China. J Rheumatol:1289–1295 Feng X, Zou Y, Pan W, Wang X, Wu M, Zhang M et al (2011) Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China. J Rheumatol:1289–1295
22.
go back to reference Fei Y, Shi X, Gan F, Li X, Zhang W, Li M, Hou Y, Zhang X, Zhao Y, Zeng X, Zhang F (2014) Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol 33:57–63CrossRefPubMed Fei Y, Shi X, Gan F, Li X, Zhang W, Li M, Hou Y, Zhang X, Zhao Y, Zeng X, Zhang F (2014) Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol 33:57–63CrossRefPubMed
23.
go back to reference Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N (2012) Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res 64:159–168CrossRef Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N (2012) Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res 64:159–168CrossRef
24.
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum:1271–1277 Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum:1271–1277
25.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum:1725 Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum:1725
26.
go back to reference Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum:630–640 Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum:630–640
27.
go back to reference Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF (2011) Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum:1182–1189 Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF (2011) Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum:1182–1189
28.
go back to reference Feng X, Pan W, Liu L, Wu M, Ding F, Hu H et al (2016) Prognosis for hospitalized patients with systemic lupus erythematosus in China: 5-year update of the Jiangsu cohort. PloS One:e0168619 Feng X, Pan W, Liu L, Wu M, Ding F, Hu H et al (2016) Prognosis for hospitalized patients with systemic lupus erythematosus in China: 5-year update of the Jiangsu cohort. PloS One:e0168619
29.
go back to reference Kang KY, Kwok SK, Ju JH, Park KS, Cho CS, Kim HY et al (2011) The causes of death in Korean patients with systemic lupus erythematosus over 11 years. Lupus:989–997 Kang KY, Kwok SK, Ju JH, Park KS, Cho CS, Kim HY et al (2011) The causes of death in Korean patients with systemic lupus erythematosus over 11 years. Lupus:989–997
30.
go back to reference Danza A, Ruiz-Irastorza G (2013) Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus. p. 1286-94 Danza A, Ruiz-Irastorza G (2013) Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus. p. 1286-94
31.
go back to reference Yee CS, Su L, Toescu V, Hickman R, Situnayake D, Bowman S et al (2015) Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years. Rheumatology:836–843 Yee CS, Su L, Toescu V, Hickman R, Situnayake D, Bowman S et al (2015) Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years. Rheumatology:836–843
32.
go back to reference Gustafsson JT, Svenungsson E (2014) Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus. Autoimmunity:67–76 Gustafsson JT, Svenungsson E (2014) Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus. Autoimmunity:67–76
33.
go back to reference Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M (2016) Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 37:3232–3245CrossRefPubMed Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M (2016) Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 37:3232–3245CrossRefPubMed
34.
go back to reference De Fatima Marinho De Souza M, Gawryszewski VP, Ordunez P, Sanhueza A, Espinal MA (2012) Cardiovascular disease mortality in the Americas: current trends and disparities. Heart:1207–1212 De Fatima Marinho De Souza M, Gawryszewski VP, Ordunez P, Sanhueza A, Espinal MA (2012) Cardiovascular disease mortality in the Americas: current trends and disparities. Heart:1207–1212
35.
go back to reference Weiwei C, Runlin G, Lisheng L, Manlu Z, Wen W, Yongjun W, Zhaosu W, Huijun L, Zhe Z, Lixin J, Shengshou H (2016) Outline of the report on cardiovascular diseases in China, 2014. Eur Heart J Suppl 18:F2–F11CrossRefPubMed Weiwei C, Runlin G, Lisheng L, Manlu Z, Wen W, Yongjun W, Zhaosu W, Huijun L, Zhe Z, Lixin J, Shengshou H (2016) Outline of the report on cardiovascular diseases in China, 2014. Eur Heart J Suppl 18:F2–F11CrossRefPubMed
Metadata
Title
Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort
Authors
Xin-yao Wu
Min Yang
Yue-sheng Xie
Wei-guo Xiao
Jin Lin
Bin Zhou
Xin Guan
Cai-nan Luo
Nan Che
Xing-zhen Liu
Chao Wang
Jia-lin Teng
Xiao-bing Cheng
Jun-na Ye
Yu-tong Su
Hui Shi
Yu-feng Yin
Meng-ru Liu
Yue Sun
Qiong-Yi Hu
Zhuo-chao Zhou
Hui-hui Chi
Yi Liu
Xiao Zhang
Jin-wei Chen
Miao-jia Zhang
Dong-bao Zhao
Cheng-de Yang
Li-jun Wu
Hong-lei Liu
Publication date
01-01-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 1/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4259-z

Other articles of this Issue 1/2019

Clinical Rheumatology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.